留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

应中央军委要求,2022年9月起,《药学实践杂志》将更名为《药学实践与服务》,双月刊,正文96页;2023年1月起,拟出版月刊,正文64页,数据库收录情况与原《药学实践杂志》相同。欢迎作者踊跃投稿!

肝细胞癌循环肿瘤细胞与肿瘤转移和预后关系的研究

王真 徐增辉 郑罗凝 王颖 孙保木 金华君 钱其军

王真, 徐增辉, 郑罗凝, 王颖, 孙保木, 金华君, 钱其军. 肝细胞癌循环肿瘤细胞与肿瘤转移和预后关系的研究[J]. 药学实践与服务, 2015, 33(2): 159-162,192. doi: 10.3969/j.issn.1006-0111.2015.02.018
引用本文: 王真, 徐增辉, 郑罗凝, 王颖, 孙保木, 金华君, 钱其军. 肝细胞癌循环肿瘤细胞与肿瘤转移和预后关系的研究[J]. 药学实践与服务, 2015, 33(2): 159-162,192. doi: 10.3969/j.issn.1006-0111.2015.02.018
WANG Zhen, XU Zenghui, ZHENG Luoning, WANG Ying, SUN Baomu, JIN Huajun, QIAN Qijun. Study on the relationship of circulating tumor cells and metastasis and prognosis of hepatocellular carcinoma[J]. Journal of Pharmaceutical Practice and Service, 2015, 33(2): 159-162,192. doi: 10.3969/j.issn.1006-0111.2015.02.018
Citation: WANG Zhen, XU Zenghui, ZHENG Luoning, WANG Ying, SUN Baomu, JIN Huajun, QIAN Qijun. Study on the relationship of circulating tumor cells and metastasis and prognosis of hepatocellular carcinoma[J]. Journal of Pharmaceutical Practice and Service, 2015, 33(2): 159-162,192. doi: 10.3969/j.issn.1006-0111.2015.02.018

肝细胞癌循环肿瘤细胞与肿瘤转移和预后关系的研究

doi: 10.3969/j.issn.1006-0111.2015.02.018
基金项目: 国家自然科学基金(No.81301307);国家传染病防治重大专项(No.2013ZX10002-010-007);上海细胞治疗工程技术研究中心科研基金(No.12DZ2251600);上海市卫生局科研基金(No.20114179)

Study on the relationship of circulating tumor cells and metastasis and prognosis of hepatocellular carcinoma

  • 摘要: 目的 研究肝细胞癌(hepatocellular carcinoma, HCC)患者外周血循环肿瘤细胞(circulating tumor cell, CTC)与肿瘤转移和预后的关系。 方法 选取35例肝细胞癌患者, 应用密度梯度离心法联合免疫磁珠阴性富集法富集CTC, 然后利用染色体荧光原位杂交和细胞免疫荧光技术进行CTC鉴定并计数, 同时记录临床相关特征, 对数据进行统计学分析。 结果 所有患者均检出CTC, 阳性率为100%, CTC个数均值为(4.1±2.5) 个。对患者进行分组, Ⅰ组的CTC个数<5, Ⅱ组的CTC数量≥5。Ⅰ组、Ⅱ组的CTC数量差异有统计学意义(P=0.001), 患者的性别、年龄与肿瘤转移无关(P=0.581、0.531), CTC的数量与转移及预后有关(P=0.024、0.01),Ⅰ组、Ⅱ组的转移和预后差异有统计学意义。 结论 HCC患者外周血CTC的数量与肿瘤转移及预后有关,CTC的数量≥5时,可能肿瘤更具转移倾向,预后更差,患者生存期更短。
  • [1] Cha C, Fong Y, Jarnagin WR, et al. Predictors and patterns of recurrence after resection of hepatocellular carcinoma[J]. J Am Coll Surg, 2003, 197(5): 753-758.
    [2] Pantel K, Brakenhoff RH. Dissecting the metastatic cascade[J]. Nat Rev Cancer, 2004, 4(6): 448-456.
    [3] Shao C, Liao CP, Hu P, et al. Detection of live circulating tumor cells by a class of near-infrared heptamethine carbocyanine dyes in patients with localized and metastatic prostate cancer[J]. PLoS One, 2014, 9(2): e88967.
    [4] Seeberg LT, Waage A, Brunborg C, et al. Circulating tumor cells in patients with colorectal liver metastasis predict impaired survival[J]. Ann Surg, 2015, 261(1): 164-171.
    [5] Mikulova V, Cabinakova M, Janatkova I, et al. Detection of circulating tumor cells during follow-up of patients with early breast cancer: clinical utility for monitoring of therapy efficacy[J]. Scand J Clin Lab Invest, 2014, 74(2): 132-142.
    [6] Muinelo-Romay L, Vieito M, Abalo A, et al. Evaluation of circulating tumor cells and related events as prognostic factors and surrogate biomarkers in advanced NSCLC patients receiving first-line systemic treatment[J]. Cancers (Basel), 2014, 6(1): 153-165.
    [7] Poveda A, Kaye SB, McCormack R, et al. Circulating tumor cells predict progression free survival and overall survival in patients with relapsed/recurrent advanced ovarian cancer[J]. Gynecol Oncol, 2011, 122(3): 567-572.
    [8] Zigeuner RE, Riesenberg R, Pohla H, et al. Isolation of circulating cancer cells from whole blood by immunomagnetic cell enrichment and unenriched immunocytochemistry in vitro[J]. J Urol, 2003, 169(2): 701-705.
    [9] Wu C, Hao H, Li L, et al. Preliminary investigation of the clinical significance of detecting circulating tumor cells enriched from lung cancer patients[J]. J Thorac Oncol, 2009, 4(1): 30-36.
    [10] Gisselsson D.Refined characterisation of chromosome aberrations in tumours by multicolour banding and electronic mapping resources[J].Methods Cell Sci,2001,23(1-3):23-28.
    [11] Ashworth TR. A case of cancer in which cells similar to those in the tumors were seen in the blood after death[J]. Aust Med J, 1869, 14(146-149.
    [12] Yu M, Bardia A, Wittner BS, et al. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition[J]. Science, 2013, 339(6119): 580-584.
    [13] Labelle M, Begum S, Hynes RO. Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis[J]. Cancer Cell, 2011, 20(5): 576-590.
    [14] 曹宇勃,许崇安. 循环肿瘤细胞预测肝细胞癌患者临床预后价值的Meta分析[J]. 中国全科医学, 2014, 17(12): 1394-1399.
    [15] Sun YF, Xu Y, Yang XR, et al. Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection[J]. Hepatology, 2013, 57(4): 1458-1468.
  • [1] 马兹芬, 许维恒, 金煜翔, 薛磊.  食管癌的靶向治疗与免疫治疗研究进展 . 药学实践与服务, 2024, 42(6): 231-237. doi: 10.12206/j.issn.2097-2024.202306008
    [2] 刘丽艳, 余小翠, 孙传铎.  纳武利尤单抗治疗非小细胞肺癌有效性及安全性的Meta分析 . 药学实践与服务, 2024, 42(10): 451-456. doi: 10.12206/j.issn.2097-2024.202310044
    [3] 迟文雅, 袁艳, 李伟林, 吴茼妤, 俞媛.  负载骨髓间充质干细胞/白藜芦醇脂质体的水凝胶支架用于创伤性脑损伤治疗 . 药学实践与服务, 2024, 42(): 1-8. doi: 10.12206/j.issn.2097-2024.202406034
    [4] 宋雨桐, 夏德润, 顾珩, 唐少文, 易洪刚, 沃红梅.  帕博利珠单抗与铂类化疗方案在晚期非小细胞肺癌一线治疗中的药物经济学评价 . 药学实践与服务, 2024, 42(8): 334-340. doi: 10.12206/j.issn.2097-2024.202303023
    [5] 冯志惠, 邓仪卿, 叶冰, 安培, 张宏, 张海军.  雀梅藤石油醚提取物诱导三阴性乳腺癌细胞凋亡的实验研究 . 药学实践与服务, 2024, 42(6): 253-259. doi: 10.12206/j.issn.2097-2024.202311055
    [6] 修建平, 杨朝爱, 刘禧澳, 潘乾禹, 韦广旭, 王卫星.  全反式维甲酸对肝星状细胞活化及氧化应激的作用和机制探索 . 药学实践与服务, 2024, 42(7): 291-296. doi: 10.12206/j.issn.2097-2024.202312054
    [7] 姜涛, 徐卫凡, 蒋益萍, 夏天爽, 辛海量.  巴戟天丸组方对Aβ损伤成骨细胞的作用及基于网络药理学的机制研究 . 药学实践与服务, 2024, 42(7): 285-290, 296. doi: 10.12206/j.issn.2097-2024.202305011
    [8] 杨媛媛, 安晓强, 许佳捷, 江键, 梁媛媛.  正极性驻极体联合5-氟尿嘧啶对瘢痕成纤维细胞生长抑制的协同作用 . 药学实践与服务, 2024, 42(6): 244-247. doi: 10.12206/j.issn.2097-2024.202310027
  • 加载中
计量
  • 文章访问数:  4930
  • HTML全文浏览量:  308
  • PDF下载量:  678
  • 被引次数: 0
出版历程
  • 收稿日期:  2014-11-01
  • 修回日期:  2015-01-29

肝细胞癌循环肿瘤细胞与肿瘤转移和预后关系的研究

doi: 10.3969/j.issn.1006-0111.2015.02.018
    基金项目:  国家自然科学基金(No.81301307);国家传染病防治重大专项(No.2013ZX10002-010-007);上海细胞治疗工程技术研究中心科研基金(No.12DZ2251600);上海市卫生局科研基金(No.20114179)

摘要: 目的 研究肝细胞癌(hepatocellular carcinoma, HCC)患者外周血循环肿瘤细胞(circulating tumor cell, CTC)与肿瘤转移和预后的关系。 方法 选取35例肝细胞癌患者, 应用密度梯度离心法联合免疫磁珠阴性富集法富集CTC, 然后利用染色体荧光原位杂交和细胞免疫荧光技术进行CTC鉴定并计数, 同时记录临床相关特征, 对数据进行统计学分析。 结果 所有患者均检出CTC, 阳性率为100%, CTC个数均值为(4.1±2.5) 个。对患者进行分组, Ⅰ组的CTC个数<5, Ⅱ组的CTC数量≥5。Ⅰ组、Ⅱ组的CTC数量差异有统计学意义(P=0.001), 患者的性别、年龄与肿瘤转移无关(P=0.581、0.531), CTC的数量与转移及预后有关(P=0.024、0.01),Ⅰ组、Ⅱ组的转移和预后差异有统计学意义。 结论 HCC患者外周血CTC的数量与肿瘤转移及预后有关,CTC的数量≥5时,可能肿瘤更具转移倾向,预后更差,患者生存期更短。

English Abstract

王真, 徐增辉, 郑罗凝, 王颖, 孙保木, 金华君, 钱其军. 肝细胞癌循环肿瘤细胞与肿瘤转移和预后关系的研究[J]. 药学实践与服务, 2015, 33(2): 159-162,192. doi: 10.3969/j.issn.1006-0111.2015.02.018
引用本文: 王真, 徐增辉, 郑罗凝, 王颖, 孙保木, 金华君, 钱其军. 肝细胞癌循环肿瘤细胞与肿瘤转移和预后关系的研究[J]. 药学实践与服务, 2015, 33(2): 159-162,192. doi: 10.3969/j.issn.1006-0111.2015.02.018
WANG Zhen, XU Zenghui, ZHENG Luoning, WANG Ying, SUN Baomu, JIN Huajun, QIAN Qijun. Study on the relationship of circulating tumor cells and metastasis and prognosis of hepatocellular carcinoma[J]. Journal of Pharmaceutical Practice and Service, 2015, 33(2): 159-162,192. doi: 10.3969/j.issn.1006-0111.2015.02.018
Citation: WANG Zhen, XU Zenghui, ZHENG Luoning, WANG Ying, SUN Baomu, JIN Huajun, QIAN Qijun. Study on the relationship of circulating tumor cells and metastasis and prognosis of hepatocellular carcinoma[J]. Journal of Pharmaceutical Practice and Service, 2015, 33(2): 159-162,192. doi: 10.3969/j.issn.1006-0111.2015.02.018
参考文献 (15)

目录

    /

    返回文章
    返回